Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q1 2024

Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.

Institution overview
Positions
65
+8 vs. Q4 2023
Portfolio value
$3.48B
+$624.3M (+21.9%) vs. Q4 2023
Filed
May 15, 2024
SEC
Holdings of Deep Track Capital, LP in Q1 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
SWTXSpringWorks Therapeutics, Inc.COM3,479,853$171.3M4.9%−583,823−14.4%ReducedHistory
AMGNAmgen IncStock550,000$156.4M4.5%+550,000NewHistory
APGEApogee Therapeutics, Inc.COM2,323,456$154.4M4.4%00.0%UnchangedHistory
INSMINSMED IncCOM PAR $.014,783,679$129.8M3.7%−566,321−10.6%ReducedHistory
DYNDyne Therapeutics, Inc.COM4,555,383$129.3M3.7%+2,555,383+127.8%AddedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM832,310$124.4M3.6%+832,310NewHistory
GHGuardant Health, Inc.COM6,000,000$123.8M3.6%+1,000,000+20.0%AddedHistory
ARGXArgenx SESPONSORED ADR300,000$118.1M3.4%00.0%UnchangedHistory
NTLAIntellia Therapeutics, Inc.COM4,210,784$115.8M3.3%+1,960,784+87.1%AddedHistory
OCULOcular Therapeutix, IncCOM12,721,460$115.8M3.3%+3,490,691+37.8%AddedHistory
DVAXDynavax Technologies CorpCOM NEW9,141,660$113.4M3.3%+2,048,446+28.9%AddedHistory
AXSMAxsome Therapeutics, Inc.COM1,304,721$104.1M3.0%+304,721+30.5%AddedHistory
ITCIIntra-Cellular Therapies, Inc.COM1,500,000$103.8M3.0%−500,000−25.0%ReducedHistory
GERNGeron CorpCOM30,505,929$100.7M2.9%+922,480+3.1%AddedHistory
AUTLAutolus Therapeutics plcSPON ADS15,272,172$97.4M2.8%+3,402,875+28.7%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM3,034,453$96.7M2.8%+750,081+32.8%AddedHistory
ALKSAlkermes plc.SHS3,500,000$94.7M2.7%−500,000−12.5%ReducedHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS3,490,506$86.9M2.5%00.0%UnchangedHistory
PLRXPliant Therapeutics, Inc.COM5,750,000$85.7M2.5%00.0%UnchangedHistory
DFTXDefinium Therapeutics, Inc.Stock6,666,667$62.7M1.8%+6,666,667NewHistory
ABVXAbivax S.A.SPONSORED ADS4,297,438$61.5M1.8%00.0%UnchangedHistory
VRDNViridian Therapeutics, Inc.COM3,456,053$60.5M1.7%−175,675−4.8%ReducedHistory
IONSIonis Pharmaceuticals IncCOM1,373,475$59.5M1.7%+124,407+10.0%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM1,000,000$58.8M1.7%+1,000,000NewHistory
ANIPAni Pharmaceuticals IncCOM822,001$56.8M1.6%+222,001+37.0%AddedHistory
TVTXTravere Therapeutics, Inc.COM7,370,000$56.8M1.6%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS3,187,415$51.3M1.5%00.0%UnchangedHistory
KYMRKymera Therapeutics, Inc.COM1,262,246$50.7M1.5%+1,262,246NewHistory
IVVDInvivyd, Inc.COM10,953,937$48.6M1.4%+10,953,937NewHistory
SYRESpyre Therapeutics, Inc.COM NEW1,213,420$46.0M1.3%−739,340−37.9%ReducedHistory
NRIXNurix Therapeutics, Inc.COM2,997,830$44.1M1.3%00.0%UnchangedHistory
HLVXHilleVax, Inc.COM2,572,460$42.8M1.2%−327,540−11.3%ReducedHistory
EDITEditas Medicine, Inc.COM5,527,290$41.0M1.2%+54,204+1.0%AddedHistory
FATEFate Therapeutics IncCOM5,572,607$40.9M1.2%+5,572,607NewHistory
TERNTerns Pharmaceuticals, Inc.COM6,100,000$40.0M1.2%00.0%UnchangedHistory
ENGNenGene Therapeutics Inc.COM2,250,000$38.1M1.1%+2,250,000NewHistory
TRMLTourmaline Bio, Inc.COM1,595,400$36.5M1.1%−220,454−12.1%ReducedHistory
OLMAOlema Pharmaceuticals, Inc.COM3,225,419$36.5M1.0%+1,294,525+67.0%AddedHistory
SLNSilence Therapeutics plcADS1,643,881$35.5M1.0%−307,699−15.8%ReducedHistory
PACBPacific Biosciences of California, Inc.COM7,000,000$26.3M0.8%00.0%UnchangedHistory
Cybin Ord23256X100COM58,139,535$24.0M0.7%+58,139,535New–
ALECAlector, Inc.COM3,769,386$22.7M0.7%+3,769,386NewHistory
NUVLNuvalent, Inc.COM274,512$20.6M0.6%−175,488−39.0%ReducedHistory
AGENAgenus IncCOM NEW31,697,539$18.4M0.5%00.0%UnchangedHistory
PYXSPyxis Oncology, Inc.COMMON STOCK4,184,100$17.8M0.5%+4,184,100NewHistory
NKTRNektar TherapeuticsCOM18,400,000$17.2M0.5%00.0%UnchangedHistory
IMVTImmunovant, Inc.COM493,352$15.9M0.5%−506,648−50.7%ReducedHistory
NMRANeumora Therapeutics, Inc.COM1,000,000$13.8M0.4%+1,000,000NewHistory
RPTXRepare Therapeutics Inc.COM2,684,344$12.6M0.4%−308,387−10.3%ReducedHistory
SRRKScholar Rock Holding CorpCOM680,000$12.1M0.3%−331,829−32.8%ReducedHistory
ANABAnaptysbio, IncCOM529,452$11.9M0.3%−1,507,538−74.0%ReducedHistory
RGLSRegulus Therapeutics Inc.COM3,266,566$9.41M0.3%+3,266,566NewHistory
ANROAlto Neuroscience, Inc.COM SHS600,000$9.21M0.3%+600,000NewHistory
RAREUltragenyx Pharmaceutical Inc.COM167,784$7.83M0.2%+167,784NewHistory
ZURAZura Bio LtdCLASS A ORD SHS2,523,000$6.48M0.2%00.0%UnchangedHistory
ALLKAllakos Inc.COM5,000,000$6.30M0.2%+2,489,264+99.1%AddedHistory
ALGSAligos Therapeutics, Inc.COM6,102,770$5.98M0.2%00.0%UnchangedHistory
RLMDRelmada Therapeutics, Inc.COM1,240,034$5.77M0.2%−804,473−39.3%ReducedHistory
VIGLVigil Neuroscience, Inc.COM1,594,931$5.44M0.2%00.0%UnchangedHistory
MGXMetagenomi Therapeutics, Inc.COM466,232$4.92M0.1%+466,232NewHistory
SYRSSyros Pharmaceuticals, Inc.COM NEW828,485$4.43M0.1%00.0%UnchangedHistory
MRSNMersana Therapeutics, Inc.COM579,674$2.60M0.1%+579,674NewHistory
PRMEPrime Medicine, Inc.COM303,716$2.13M0.1%+303,716NewHistory
COGTCogent Biosciences, Inc.COM316,000$2.12M0.1%+316,000NewHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS40,137$1.72M<0.1%−259,863−86.6%ReducedHistory

Options (1)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q1 2024
SecurityClassPutsCalls
ITCIIntra-Cellular Therapies, Inc.COM$12.1M–

Sold out since Q4 2023 (11)

Positions held at the end of Q4 2023 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q4 2023
SecurityClassShares in Q4 2023Value in Q4 2023% of portfolio in Q4 2023History
AMAMAmbrx Biopharma, Inc.COM3,710,412$52.8M1.9%History
SRPTSarepta Therapeutics, Inc.COM500,000$48.2M1.7%History
RAPTRAPT Therapeutics, Inc.COM1,793,966$44.6M1.6%History
ACLXArcellx, Inc.COMMON STOCK725,145$40.2M1.4%History
ORTXOrchard Therapeutics plcSPON ADS NEW2,041,670$33.6M1.2%History
EWTXEdgewise Therapeutics, Inc.COM2,537,176$27.8M1.0%History
CYTKCytokinetics IncCOM NEW288,949$24.1M0.8%History
AGIOAgios Pharmaceuticals, Inc.COM1,062,881$23.7M0.8%History
PTGXProtagonist Therapeutics, IncCOM275,201$6.31M0.2%History
JAZZJazz Pharmaceuticals plcSHS USD48,280$5.94M0.2%History
GHRSGH Research PLCORDINARY SHARES499,400$2.90M0.1%History